课题基金 / 基金详情

Relationship between p27^<Kip1> expression and tumor differention and prognosis in human oral squamous cell carcinoma.

Relationship between p27^<Kip1> expression and tumor differention and prognosis in human oral squamous cell carcinoma.
人口腔鳞癌p27^<Kip1>表达与肿瘤分化及预后的关系。
批准号:
11671990
负责人:
HARADA Koji
金额:
$0.45万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

HARADA Koji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have investigated the expression of p27^<Kip1> in oral squamous cell carcinomas (OSCCs) using immunohistochemistry and have tried to investigate the relationship between each expression level and clinico-pathological characteristics such as tumor grade, T, N, stage classifications, effect and outcome. High levels of p27^<Kip1> expression were significantly related to well differentiated cases(p<0.05), NO cases (p<0.01), non advanced cases (p<0.01), and good effective cases (p<0.05). Five-year survival rate of p27^<Kip1> high expression cases was 63.3%, and it was significantly high than that of p27^<Kip1> low expression cases (45.5%) (p<0.05). By Cox's proportional hazards model, high levels of p27^<Kip1> expression significantly made the rate of death decrease. These results suggested that p27^<Kip1> protein expression may be closely related to tumor grade, inhibition of metastasis, effect and outcome, and an useful prognostic marker. Next, we have constructed p27^<Kip1> expression vectors with pcDNA3.1 (stratagene). Moreover, we transfected them to OSCC cell line (B88) in sense or anti-sense oriented, and tried to regulate the p27^<Kip1> gene in B88 cells. Overexpression of p27^<Kip1> in B88 cells (B88/Tp27sense) inhibited the growth, invasion and metastasis of them. Contradictory, low expression of p27^<Kip1> in B88 cells (B88/Tp27anti-sense) promoted the growth, invasion and metastasis. On tumor differentiation, we could detect the morphological change from squamous cell type to spindol cell type in B88/Tp27anti-sense though we could not detect the difference between parental B88 and B88/Tp27sense by HE staining. Moreover, we could detect the induction of involucrin and keratin 7,8 (Cam 5.2) in B88/Tp27sense immunohistochemically. These results suggested that p27^<Kip1> might be related to terminal differentiation of OSSC.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Carlile J: "VEGF expression in oral tissues, Possible relevance to angiogenesis, tumour progression and field cancerisation."J Oral Pathol Med. (in press).
Carlile J:“口腔组织中的 VEGF 表达,可能与血管生成、肿瘤进展和局部癌化相关。”J Oral Pathol Med。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Harada K, Lu S, Chisholm MD, Syrjnen S and Schor AM: "Angiogenesis and vasodilation in skin warts. Association with HPV infection."Anticancer Res. 20. 4519-4524 (2000)
Harada K、Lu S、Chisholm MD、Syrjnen S 和 Schor AM:“皮肤疣中的血管生成和血管舒张。与 HPV 感染的关联。”抗癌研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Motegi K: "Effect of a mutant form of 1kB-α on 5-fluorouracil-induced apoptosis in transformed human salivary gland cells."Oral Oncol, Eur J Cancer. 37. 185-192 (2001)
Motegi K:“1kB-α 突变体对转化人唾液腺细胞中 5-氟尿嘧啶诱导的细胞凋亡的影响。”Oral Oncol,Eur J Cancer 37. 185-192 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Harada K and Ogden GR: "An overview of the cell cycle arrest protein p21^<WAF1>"Oral Oncol, Eur J Cancer. 36. 3-7 (2000)
Harada K 和 Ogden GR:“细胞周期阻滞蛋白 p21^<WAF1> 的概述”Oral Oncol,Eur J Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
18
    Development of novel treatment against refractory oral cancer by uptake inhibition of iron or induction of ferroptosis
    • 批准号:
      18K09814
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2018
    • 负责人:
      HARADA Koji
    • 依托单位:
    Development of new oral cancer treatments focused on mTOR inhibition leading to the anti-aging prevention and the healthy life-span extension
    • 批准号:
      15K11292
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      HARADA Koji
    • 依托单位:
    Development of a novel functional preservation therapy against advanced, recurrent or unresectable oral cancers.
    • 批准号:
      24593034
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.41万
    • 财政年份:
      2012
    • 负责人:
      HARADA Koji
    • 依托单位:
    Examination of the physical pictures of the field theories with nonlinearly realized symmetries by the Wilsonian renormalization group method
    • 批准号:
      22540286
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.83万
    • 财政年份:
      2010
    • 负责人:
      HARADA Koji
    • 依托单位:
    海外基金